Monthly Archives: March 2016

The Role of Volumetric Neuroimaging in the Evaluation of Multiple Sclerosis

Automated volumetric MR imaging offers an opportunity to extend brain atrophy measurements to the routine management of Multiple Sclerosis (MS) patients by showing regional and whole brain atrophy, which can be monitored over time. In MS patients, brain volume loss,...
Continue Reading →

Interested in Ensuring Accurate NeuroQuant Output Results?

Over the past few months, we have explored several factors which can degrade the technical quality of MR images or pathologic processes, and significantly affect neuroanatomic structure, which may decrease the accuracy of NeuroQuant® output. Below is a compilation of...
Continue Reading →

2016 Brain Awareness Week Focus: Multiple Sclerosis and Neurodegeneration

According to the MS International Federation, multiple sclerosis (MS) is one of the most common diseases of the central nervous system, and more than 2,300,000 people worldwide are living with the diagnosis of MS. MS is defined as an immune-mediated...
Continue Reading →

New Product from CorTechs Labs: PETQuant for Research Use

On March 9, 2016, CorTechs Labs launched a new research product: PETQuant™. PETQuant provides automated and fast post-acquisition analyses of PET brain studies to quantify subregional tracer binding in native patient brain space, and is compatible with metabolic (FDG) and...
Continue Reading →

Revolutionizing Reporting: NeuroQuant Now Supports PowerScribe 360

Have you heard the news? NeuroQuant®’s automated, quantitative MRI analysis can now be integrated with PowerScribe® 360 to streamline dictation of NeuroQuant results. Why is this important? NeuroQuant, is a leading medical device software which automatically labels, segments and quantifies...
Continue Reading →